Shuaige Wang
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Monoclonal and Polyclonal Antibodies Research, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Atrial Fibrillation Management and Outcomes, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa(2001)172 cited
- → Discovery of Potent Isoxazoline Glycoprotein IIb/IIIa Receptor Antagonists(1997)72 cited
- → Discovery of an Orally Active Series of Isoxazoline Glycoprotein IIb/IIIa Antagonists(1997)66 cited
- → SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and Xa(2004)41 cited
- → Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core(2001)40 cited
- → Chemistry and pharmacokinetics of diarylthiophenes and terphenyls as selective COX-2 inhibitors(1996)37 cited
- → Terphenyl cyclooxygenase-2 (COX-2) inhibitors: Optimization of the central ring and o-biphenyl analogs(1999)22 cited
- → Sulfonamidolactam inhibitors of coagulation factor Xa(2008)13 cited
- → Identification and characterization of antibodies that bind GPIIb/IIIa: Antagonist complexes(2005)10 cited
- → The Discovery of Potent Isoxazoline Glycoprotein IIb/IIIa Receptor Antagonists(1997)5 cited